Massachusetts General Hospital — Boston, Massachusetts

Public research footprint of Massachusetts General Hospital, compiled from the ClinicalTrials.gov public registry.

5,764

Registered studies

1,543

Active

769

Recruiting now

3,151

Completed

819

Stopped or withdrawn

Most-studied conditions

PDAC - Pancreatic Ductal Adenocarcinoma · B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative · Myelodysplastic Syndrome With Excess Blasts-1 · Metastatic Non-Cutaneous Melanoma

Recently updated registry entries

NCT06690398 — Multicenter Study of Lumateperone for the Treatment of Irritability Associated With… (Recruiting)
NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Massachusetts General Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.